LeMaitre Vascular - 19 Year Stock Price History | LMAT
- The all-time high LeMaitre Vascular stock closing price was 107.70 on November 22, 2024.
- The LeMaitre Vascular 52-week high stock price is 109.58, which is 33.9% above the current share price.
- The LeMaitre Vascular 52-week low stock price is 62.39, which is 23.8% below the current share price.
- The average LeMaitre Vascular stock price for the last 52 weeks is 87.72.
LeMaitre Vascular Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 92.4485 | 91.2456 | 103.7450 | 78.8200 | 81.8400 | -10.96% |
2024 | 79.2683 | 56.1217 | 107.7050 | 53.4398 | 91.9139 | 63.63% |
2023 | 54.4513 | 44.5028 | 67.1555 | 43.8171 | 56.1712 | 24.60% |
2022 | 45.4023 | 49.9163 | 54.5657 | 37.9470 | 45.0807 | -7.40% |
2021 | 50.2470 | 38.6183 | 61.1342 | 38.6183 | 48.6853 | 25.10% |
2020 | 29.3394 | 33.9670 | 39.6561 | 20.0200 | 38.9162 | 14.09% |
2019 | 28.5825 | 21.9481 | 34.3560 | 21.0661 | 34.1093 | 53.77% |
2018 | 31.1783 | 28.9583 | 38.2432 | 20.6532 | 22.1827 | -25.13% |
2017 | 27.9986 | 23.3058 | 36.3536 | 20.2298 | 29.6283 | 26.58% |
2016 | 15.9460 | 14.4594 | 23.5183 | 11.4250 | 23.4075 | 48.46% |
2015 | 10.2631 | 7.0436 | 16.2417 | 6.5663 | 15.7665 | 128.82% |
2014 | 6.7820 | 7.0750 | 7.4850 | 5.9155 | 6.8905 | -2.73% |
2013 | 5.9127 | 5.0052 | 7.6233 | 5.0052 | 7.0838 | 42.02% |
2012 | 5.0832 | 4.9034 | 5.6483 | 4.2908 | 4.9879 | -1.37% |
2011 | 5.6166 | 5.8555 | 6.3649 | 4.5105 | 5.0572 | -11.46% |
2010 | 4.8472 | 4.2018 | 6.1423 | 3.7293 | 5.7120 | 35.40% |
2009 | 2.7835 | 1.8056 | 4.2186 | 1.6115 | 4.2186 | 116.64% |
2008 | 3.0305 | 5.0624 | 5.6614 | 1.5693 | 1.9473 | -62.77% |
2007 | 5.4664 | 5.1045 | 6.4545 | 4.6911 | 5.2311 | 3.33% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.893B | $0.220B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
Boston Scientific (BSX) | United States | $149.209B | 40.19 |
Stryker (SYK) | United States | $142.084B | 30.54 |
EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
Medtronic (MDT) | Ireland | $115.249B | 16.83 |
Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
Agilent Technologies (A) | United States | $33.351B | 22.03 |
ResMed (RMD) | United States | $32.876B | 25.32 |
Terumo (TRUMY) | Japan | $27.805B | 39.54 |
Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
Insulet (PODD) | United States | $18.442B | 78.86 |
Baxter (BAX) | United States | $17.557B | 12.63 |
Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
Demant (WILYY) | Denmark | $8.048B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.405B | 29.11 |
Haemonetics (HAE) | United States | $3.193B | 15.02 |
Envista Holdings (NVST) | United States | $2.972B | 23.64 |
QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
Neogen (NEOG) | United States | $1.881B | 21.67 |
AtriCure (ATRC) | United States | $1.577B | 0.00 |
AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
InMode (INMD) | Israel | $1.234B | 10.31 |
Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
Evolus (EOLS) | United States | $0.765B | 0.00 |
Owens & Minor (OMI) | United States | $0.698B | 5.94 |
CeriBell (CBLL) | United States | $0.689B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
Valneva SE (VALN) | France | $0.545B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
Omeros (OMER) | United States | $0.476B | 0.00 |
Surmodics (SRDX) | United States | $0.436B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
SNDL (SNDL) | Canada | $0.371B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
ZimVie (ZIMV) | United States | $0.301B | 18.00 |
Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Cerus (CERS) | United States | $0.258B | 0.00 |
Quanterix (QTRX) | United States | $0.252B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
Biote (BTMD) | United States | $0.182B | 4.16 |
Brainsway (BWAY) | Israel | $0.178B | 55.71 |
TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
High Tide (HITI) | Canada | $0.153B | 0.00 |
Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
Jin Medical (ZJYL) | China | $0.116B | 0.00 |
FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Fonar (FONR) | United States | $0.087B | 12.18 |
MacroGenics (MGNX) | United States | $0.080B | 0.00 |
Veru (VERU) | United States | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.067B | 24.44 |
United Health Products (UEEC) | United States | $0.066B | 0.00 |
Exagen (XGN) | United States | $0.064B | 0.00 |
InterCure (INCR) | Israel | $0.064B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Modular Medical (MODD) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.041B | 12.66 |
Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
Safety Shot (SHOT) | United States | $0.027B | 0.00 |
INLIF (INLF) | $0.021B | 0.00 | |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |